Healthcare provider profile · identity verified

Teri T Boon, M.D.

Family Practice · YUCAIPA, CA · NPI 1114962792

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	677	209
Levothyroxine Sodium	Levothyroxine Sodium	316	92
Losartan Potassium	Losartan Potassium	314	108
Amlodipine Besylate	Amlodipine Besylate	311	108
Lisinopril	Lisinopril	263	88
Omeprazole	Omeprazole	209	86
Metformin Hcl	Metformin Hcl	192	70
Albuterol Sulfate Hfa	Albuterol Sulfate	190	93
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	169	57
Trazodone Hcl	Trazodone Hcl	161	52
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	147	29
Potassium Chloride	Potassium Chloride	147	60
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	142	47
Gabapentin	Gabapentin	139	55
Rosuvastatin Calcium	Rosuvastatin Calcium	135	46
Prednisone	Prednisone	129	112
Cephalexin	Cephalexin	126	110
Ibuprofen	Ibuprofen	122	38
Alendronate Sodium	Alendronate Sodium	120	43
Atenolol	Atenolol	107	33
Furosemide	Furosemide	107	45
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	107	35
Amoxicillin	Amoxicillin	104	100
Glipizide	Glipizide	104	38
Metoprolol Tartrate	Metoprolol Tartrate	104	33
Hydrochlorothiazide	Hydrochlorothiazide	102	38
Simvastatin	Simvastatin	101	31
Alvesco	Ciclesonide	93	52
Sertraline Hcl	Sertraline Hcl	93	33
Azelastine Hcl	Azelastine Hcl	91	28
Pantoprazole Sodium	Pantoprazole Sodium	89	31
Tramadol Hcl	Tramadol Hcl	87	22
Pradaxa	Dabigatran Etexilate Mesylate	86	25
Finasteride	Finasteride	76	27
Meloxicam	Meloxicam	76	37
Bisoprolol Fumarate	Bisoprolol Fumarate	71	26
Ciprofloxacin Hcl	Ciprofloxacin Hcl	69	60
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	66	61
Clopidogrel	Clopidogrel Bisulfate	66	18
Famotidine	Famotidine	66	20
Azithromycin	Azithromycin	64	59
Spironolactone	Spironolactone	64	21
Terazosin Hcl	Terazosin Hcl	62	23
Buspirone Hcl	Buspirone Hcl	60	21
Metformin Hcl Er	Metformin Hcl	59	24
Acyclovir	Acyclovir	58	28
Allopurinol	Allopurinol	57	20
Montelukast Sodium	Montelukast Sodium	53	18
Humulin N	Insulin Nph Human Isophane	52	16
Estradiol	Estradiol	51	25
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	51	15
Naproxen	Naproxen	46	24
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	45	45
Sumatriptan Succinate	Sumatriptan Succinate	45	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	45	14
Wixela Inhub	Fluticasone Propion/Salmeterol	43	12
Acetaminophen-Codeine	Acetaminophen With Codeine	42	suppressed
Humulin 70/30 Kwikpen	Insulin Nph Hum/Reg Insulin Hm	41	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	38	35
Metronidazole	Metronidazole	38	30
Duloxetine Hcl	Duloxetine Hcl	37	15
Eliquis	Apixaban	37	suppressed
Humulin N Kwikpen	Insulin Nph Human Isophane	37	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	36	16
Triamcinolone Acetonide	Triamcinolone Acetonide	36	27
Hydralazine Hcl	Hydralazine Hcl	35	13
Propranolol Hcl	Propranolol Hcl	35	12
Trospium Chloride	Trospium Chloride	35	14
Citalopram Hbr	Citalopram Hydrobromide	34	suppressed
Fluticasone Propionate	Fluticasone Propionate	34	suppressed
Naloxone Hcl	Naloxone Hcl	34	28
Clobetasol Propionate	Clobetasol Propionate	33	18
Carvedilol	Carvedilol	31	11
Donepezil Hcl	Donepezil Hcl	31	suppressed
Metoprolol Succinate	Metoprolol Succinate	30	suppressed
Spiriva Respimat	Tiotropium Bromide	30	suppressed
Fenofibrate	Fenofibrate	29	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	29	suppressed
Nitroglycerin	Nitroglycerin	29	20
Mupirocin	Mupirocin	28	17
Baclofen	Baclofen	27	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	27	suppressed
Veo Insulin Syringe	Syringe And Needle,insulin,1ml	27	12
Ezetimibe	Ezetimibe	26	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	26	suppressed
Pravastatin Sodium	Pravastatin Sodium	26	suppressed
Humulin R	Insulin Regular, Human	25	suppressed
Warfarin Sodium	Warfarin Sodium	24	suppressed
Alprazolam	Alprazolam	23	12
Bupropion Xl	Bupropion Hcl	22	11
Clonidine Hcl	Clonidine Hcl	22	suppressed
Methenamine Hippurate	Methenamine Hippurate	22	suppressed
Retin-A	Tretinoin	22	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	21	suppressed
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	21	suppressed
Hydrocortisone	Hydrocortisone	21	suppressed
Lovastatin	Lovastatin	21	suppressed
Cefuroxime	Cefuroxime Axetil	20	20
Nitrofurantoin	Nitrofurantoin Macrocrystal	20	15
Levetiracetam	Levetiracetam	19	suppressed
Ofloxacin	Ofloxacin	19	15
Hydromorphone Hcl	Hydromorphone Hcl	18	suppressed
Ondansetron Odt	Ondansetron	18	13
Paxlovid	Nirmatrelvir/Ritonavir	18	18
Arexvy	Rsvpref3 Antigen/As01e/Pf	17	17
Venlafaxine Hcl Er	Venlafaxine Hcl	17	suppressed
Veo Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	17	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	16	suppressed
Tradjenta	Linagliptin	16	suppressed
Fluconazole	Fluconazole	15	12
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	15	suppressed
Temazepam	Temazepam	15	suppressed
Bupropion Hcl Sr	Bupropion Hcl	14	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	14	suppressed
Nystatin	Nystatin	14	suppressed
Lidocaine	Lidocaine	13	suppressed
Morphine Sulfate	Morphine Sulfate	13	suppressed
Myrbetriq	Mirabegron	13	suppressed
Naratriptan Hcl	Naratriptan Hcl	13	suppressed
Pregabalin	Pregabalin	13	suppressed
Valacyclovir	Valacyclovir Hcl	13	suppressed
Testosterone	Testosterone	12	suppressed
Fluocinolone Acetonide	Fluocinolone/Shower Cap	11	suppressed
Ketoconazole	Ketoconazole	11	suppressed
Lacosamide	Lacosamide	11	suppressed
Megestrol Acetate	Megestrol Acetate	11	suppressed
Ondansetron Hcl	Ondansetron Hcl	11	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	11	suppressed
Ozempic	Semaglutide	11	suppressed
Tacrolimus	Tacrolimus	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error